Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation. The National Program on Targeted Radionuclide Therapy for Prostate Cancer focuses on radionuclide therapy (RNT): a new form of treatment for men with advanced prostate cancer which cannot be cured by current methods. This coordinated, national initiative aims to accelerate access to this promising and innovative treatment for Canadian men.

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer. The nationwide Prostate Cancer Canada fundraiser and awareness campaign sees scores of workplaces and individuals changing the lives of the one in seven Canadian men who will be diagnosed with the disease.

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.

Toronto (April 19, 2018) – Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumour has evolved. This information can be used to determine what type and how much treatment should be given to each patient, or if any is needed at all.

Toronto, March 12, 2018 – Funded by Prostate Cancer Canada (PCC), Dr. Kerry Courneya’s team at the University of Alberta will study whether exercise can reduce tumour growth and anxiety for men on active surveillance.  

February 23, 2018 – TORONTO, ON – For the fifth year and counting, Prostate Cancer Canada’s (PCC) Rock the Road Raffle brought together Ontarians from all walks of life to both support an important cause and gain a chance to win a one-of-a-kind dream car.

Toronto, January 29, 2018 – Funded by Prostate Cancer Canada (PCC), Dr. Anil Adisesh at Dalhousie Medicine New Brunswick, Dalhousie University, and Dr. Trevor Dummer at the Centre of Excellence in Cancer Prevention, within the School of Population and Public Health at the University of British Columbia, will lead a team analyzing the world’s largest collection of toenails, all from Atlantic Canadians, to measure individual exposures to toxic metals that are known carcinogens and may cause prostate cancer. This research is part of a wider strategy by PCC to generate new and practical knowledge in the poorly understood area of prostate cancer prevention.  

Vancouver, BC – For years, researchers have investigated approaches to prevent cancer-causing cells from multiplying in the body. Now, Vancouver Prostate Centre (VPC) scientist Dr. Christopher Ong and colleagues have discovered a critical gene that drives cancer growth. From this discovery, they developed a new protein-based medication that prevents unhealthy cell growth that leads to prostate cancer, and potentially other cancers.   Dr. Ong shows support for Prostate Cancer Canada's annual Plaid for Dad fundraiser

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists. The course will be made available in both English and French. The anticipated start date of the course will be April 2018 and the course will be made available for one year after launch. 

Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada. Peter will begin effective February 28, 2018.